Modelling A.I. in Economics

Exclusive to premium members (Forecast)

Outlook: AEMD Aethlon Medical Inc. is assigned short-term B2 & long-term B3 estimated rating.
AUC Score : What is AUC Score?
Short-Term Revised1 :
Dominant Strategy : Buy
Time series to forecast n: for Weeks2
ML Model Testing : Ensemble Learning (ML)
Hypothesis Testing : Multiple Regression
Surveillance : Major exchange and OTC

1The accuracy of the model is being monitored on a regular basis.(15-minute period)

2Time series is updated based on short-term trends.


Key Points

This exclusive content is only available to premium users.

Summary

Aethlon Medical Inc. is a clinical-stage biotechnology company developing innovative blood purification technologies for the treatment of life-threatening diseases. The company's current focus is on developing therapeutic products for the treatment of cancer, sepsis, and viral infections. Aethlon's lead product candidate, the Hemopurifier, is a device that removes circulating tumor cells and other harmful substances from the blood, thereby improving patient outcomes.

Aethlon is also developing a blood purification system for the treatment of sepsis, a life-threatening condition caused by the body's response to infection. Sepsis is a major cause of death worldwide, and Aethlon's system is designed to remove the harmful substances that contribute to the condition and improve patient outcomes.

AEMD
This exclusive content is only available to premium users.

ML Model Testing

F(Multiple Regression)6,7= p a 1 p a 2 p 1 n p j 1 p j 2 p j n p k 1 p k 2 p k n p n 1 p n 2 p n n X R(Ensemble Learning (ML))3,4,5 X S(n):→ 1 Year i = 1 n s i

n:Time series to forecast

p:Price signals of AEMD stock

j:Nash equilibria (Neural Network)

k:Dominated move of AEMD stock holders

a:Best response for AEMD target price

 

For further technical information as per how our model work we invite you to visit the article below: 

How do PredictiveAI algorithms actually work?

AEMD Stock Forecast (Buy or Sell) Strategic Interaction Table

Strategic Interaction Table Legend:

X axis: *Likelihood% (The higher the percentage value, the more likely the event will occur.)

Y axis: *Potential Impact% (The higher the percentage value, the more likely the price will deviate.)

Z axis (Grey to Black): *Technical Analysis%

This exclusive content is only available to premium users.
Rating Short-Term Long-Term Senior
Outlook*B2B3
Income StatementB2Ba3
Balance SheetB2B1
Leverage RatiosBaa2Caa2
Cash FlowCaa2C
Rates of Return and ProfitabilityCaa2C

*Financial analysis is the process of evaluating a company's financial performance and position by neural network. It involves reviewing the company's financial statements, including the balance sheet, income statement, and cash flow statement, as well as other financial reports and documents.
How does neural network examine financial reports and understand financial state of the company?This exclusive content is only available to premium users.This exclusive content is only available to premium users.This exclusive content is only available to premium users.This exclusive content is only available to premium users.

References

  1. V. Mnih, K. Kavukcuoglu, D. Silver, A. Rusu, J. Veness, M. Bellemare, A. Graves, M. Riedmiller, A. Fidjeland, G. Ostrovski, S. Petersen, C. Beattie, A. Sadik, I. Antonoglou, H. King, D. Kumaran, D. Wierstra, S. Legg, and D. Hassabis. Human-level control through deep reinforcement learning. Nature, 518(7540):529–533, 02 2015.
  2. Bertsimas D, King A, Mazumder R. 2016. Best subset selection via a modern optimization lens. Ann. Stat. 44:813–52
  3. Athey S, Tibshirani J, Wager S. 2016b. Generalized random forests. arXiv:1610.01271 [stat.ME]
  4. Van der Vaart AW. 2000. Asymptotic Statistics. Cambridge, UK: Cambridge Univ. Press
  5. Jorgenson, D.W., Weitzman, M.L., ZXhang, Y.X., Haxo, Y.M. and Mat, Y.X., 2023. MRNA: The Next Big Thing in mRNA Vaccines. AC Investment Research Journal, 220(44).
  6. Rosenbaum PR, Rubin DB. 1983. The central role of the propensity score in observational studies for causal effects. Biometrika 70:41–55
  7. Breusch, T. S. (1978), "Testing for autocorrelation in dynamic linear models," Australian Economic Papers, 17, 334–355.

Premium

  • Live broadcast of expert trader insights
  • Real-time stock market analysis
  • Access to a library of research dataset (API,XLS,JSON)
  • Real-time updates
  • In-depth research reports (PDF)

Login
This project is licensed under the license; additional terms may apply.